Your browser doesn't support javascript.
loading
Corrigendum to "Protosappanin A protects against experimental autoimmune myocarditis, and induces metabolically reprogrammed tolerogenic DCs" (Pharmacol. Res. 146 (2019) 104269).
Wu, Jian; Liu, Mingyang; Mang, Ge; Yu, Shan; Chen, Qi; Li, Tingting; Wang, Yongchen; Meng, Ying; Tang, XinYue; Zheng, Yang; Sun, Yong; Zhang, Maomao; Bo, Yu.
Afiliação
  • Wu J; Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
  • Liu M; Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
  • Mang G; Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
  • Yu S; Department of Pathology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China.
  • Chen Q; Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
  • Li T; Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
  • Wang Y; Department of General Practice, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China.
  • Meng Y; Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
  • Tang X; Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
  • Zheng Y; Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
  • Sun Y; Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
  • Zhang M; Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China. Electronic address: maomaolp1983@163.com.
  • Bo Y; Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
Pharmacol Res ; 160: 105177, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32919214
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China